Polistena, B., F. Spandonaro, R. Capra, S. Fantaccini, L. Santoni, G. Zimatore, and C. Gasperini. “The Societal Impact of Treatment With Natalizumab of relapsing–remitting Multiple Sclerosis in Italian Clinical Practice: The Tysabri® PharmacoEconomics (TyPE) Study”. Global and Regional Health Technology Assessment, vol. 6, no. 1, June 2019, doi:10.33393/grhta.2019.463.